MedPath

MELOXICAM

These highlights do not include all the information needed to use MELOXICAM TABLETS safely and effectively. See full prescribing information for MELOXICAM TABLETS. MELOXICAM tablets, for oral use Initial U.S. Approval: 2000

Approved
Approval ID

f31d181a-33cb-560f-e053-2995a90abbd9

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 25, 2023

Manufacturers
FDA

Northwind Pharmaceuticals, LLC

DUNS: 036986393

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

meloxicam

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code51655-571
Application NumberANDA077929
Product Classification
M
Marketing Category
C73584
G
Generic Name
meloxicam
Product Specifications
Route of AdministrationORAL
Effective DateJanuary 25, 2023
FDA Product Classification

INGREDIENTS (4)

SODIUM STEARATEInactive
Code: QU7E2XA9TG
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
MELOXICAMActive
Quantity: 15 mg in 1 1
Code: VG2QF83CGL
Classification: ACTIB
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

MELOXICAM - FDA Drug Approval Details